Bladder

New Immunotherapy Breakthroughs in treating Bladder Cancer

New Immunotherapy Breakthroughs in treating Bladder Cancer

Advances in metastatic bladder cancer do not come round every day, and it is big news when they do. The FDA approval of atezolizumab (Tecentriq) combined with the break-through therapy designation that nivolumab (Opdivo), things are on the upswing.

Cancer Research UK and Astex Team Up to Test DNMT Inhibitor

Cancer Research UK and Astex Team Up to Test DNMT Inhibitor

Cancer Research UK (CRUK) in conjunction with Astex has begun a Phase I/II Trial to measure the success of a DNA Methyltransferase (DNMT) inhibitor can halt the progress of bladder cancer proving resistant to chemotherapy.

Rethinking Radical Cystectomy for Patients with Muscle Invasive Bladder Cancer

Rethinking Radical Cystectomy for Patients with Muscle Invasive Bladder Cancer

Is it time for urologist to begin to rethink the radical cystectomy, and begin to explore trimodality therapy? Maybe, maybe not, depends on who you ask. Let’s go over a few things first before we jump right in though:

Heating chemo drug before using it as treatment for bladder cancer can great increase its effectiveness

Heating chemo drug before using it as treatment for bladder cancer can great increase its effectiveness

According to research published in the International Journal of Hypothermia scientists have discovered that by heating the chemo drug Mitomycin-C before administering it to patients who were undergoing chemo to treat bladder cancer.